Powerful Analgesics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB512245711

Publication Date:

December 3, 2024

Pages:

160

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Powerful analgesics are medications used to treat severe or long-term (chronic) pain.
The global market for Powerful Analgesics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Powerful Analgesics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Powerful Analgesics by region & country, by Type, and by Application.
The Powerful Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Powerful Analgesics.
麻豆原创 Segmentation
By Company
Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Akorn
Barr Pharmaceuticals
Pfizer
Watson Laboratories
Teva
KV Pharmaceutical
Lannett
Apotex
Fresenius
Johnson and Johnson
Mundipharma
Novartis
Stada Arzneimittel
Mylan
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Northeast Pharmaceutical Group
Shandong Keyuan Pharmaceutical
Segment by Type:
Morphine
Hydromorphone
Oxymorphone
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Powerful Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Powerful Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Powerful Analgesics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Powerful Analgesics Product Introduction
1.2 Global Powerful Analgesics 麻豆原创 Size Forecast
1.2.1 Global Powerful Analgesics Sales Value (2019-2030)
1.2.2 Global Powerful Analgesics Sales Volume (2019-2030)
1.2.3 Global Powerful Analgesics Sales Price (2019-2030)
1.3 Powerful Analgesics 麻豆原创 Trends & Drivers
1.3.1 Powerful Analgesics Industry Trends
1.3.2 Powerful Analgesics 麻豆原创 Drivers & Opportunity
1.3.3 Powerful Analgesics 麻豆原创 Challenges
1.3.4 Powerful Analgesics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Powerful Analgesics Players Revenue Ranking (2023)
2.2 Global Powerful Analgesics Revenue by Company (2019-2024)
2.3 Global Powerful Analgesics Players Sales Volume Ranking (2023)
2.4 Global Powerful Analgesics Sales Volume by Company Players (2019-2024)
2.5 Global Powerful Analgesics Average Price by Company (2019-2024)
2.6 Key Manufacturers Powerful Analgesics Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Powerful Analgesics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Powerful Analgesics
2.9 Powerful Analgesics 麻豆原创 Competitive Analysis
2.9.1 Powerful Analgesics 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Powerful Analgesics Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powerful Analgesics as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Morphine
3.1.2 Hydromorphone
3.1.3 Oxymorphone
3.1.4 Others
3.2 Global Powerful Analgesics Sales Value by Type
3.2.1 Global Powerful Analgesics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Powerful Analgesics Sales Value, by Type (2019-2030)
3.2.3 Global Powerful Analgesics Sales Value, by Type (%) (2019-2030)
3.3 Global Powerful Analgesics Sales Volume by Type
3.3.1 Global Powerful Analgesics Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Powerful Analgesics Sales Volume, by Type (2019-2030)
3.3.3 Global Powerful Analgesics Sales Volume, by Type (%) (2019-2030)
3.4 Global Powerful Analgesics Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Powerful Analgesics Sales Value by Application
4.2.1 Global Powerful Analgesics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Powerful Analgesics Sales Value, by Application (2019-2030)
4.2.3 Global Powerful Analgesics Sales Value, by Application (%) (2019-2030)
4.3 Global Powerful Analgesics Sales Volume by Application
4.3.1 Global Powerful Analgesics Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Powerful Analgesics Sales Volume, by Application (2019-2030)
4.3.3 Global Powerful Analgesics Sales Volume, by Application (%) (2019-2030)
4.4 Global Powerful Analgesics Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Powerful Analgesics Sales Value by Region
5.1.1 Global Powerful Analgesics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Powerful Analgesics Sales Value by Region (2019-2024)
5.1.3 Global Powerful Analgesics Sales Value by Region (2025-2030)
5.1.4 Global Powerful Analgesics Sales Value by Region (%), (2019-2030)
5.2 Global Powerful Analgesics Sales Volume by Region
5.2.1 Global Powerful Analgesics Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Powerful Analgesics Sales Volume by Region (2019-2024)
5.2.3 Global Powerful Analgesics Sales Volume by Region (2025-2030)
5.2.4 Global Powerful Analgesics Sales Volume by Region (%), (2019-2030)
5.3 Global Powerful Analgesics Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Powerful Analgesics Sales Value, 2019-2030
5.4.2 North America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Powerful Analgesics Sales Value, 2019-2030
5.5.2 Europe Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Powerful Analgesics Sales Value, 2019-2030
5.6.2 Asia Pacific Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Powerful Analgesics Sales Value, 2019-2030
5.7.2 South America Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Powerful Analgesics Sales Value, 2019-2030
5.8.2 Middle East & Africa Powerful Analgesics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Powerful Analgesics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Powerful Analgesics Sales Value
6.2.1 Key Countries/Regions Powerful Analgesics Sales Value, 2019-2030
6.2.2 Key Countries/Regions Powerful Analgesics Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Powerful Analgesics Sales Value, 2019-2030
6.3.2 United States Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Powerful Analgesics Sales Value, 2019-2030
6.4.2 Europe Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Powerful Analgesics Sales Value, 2019-2030
6.5.2 China Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Powerful Analgesics Sales Value, 2019-2030
6.6.2 Japan Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Powerful Analgesics Sales Value, 2019-2030
6.7.2 South Korea Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Powerful Analgesics Sales Value, 2019-2030
6.8.2 Southeast Asia Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Powerful Analgesics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Powerful Analgesics Sales Value, 2019-2030
6.9.2 India Powerful Analgesics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Powerful Analgesics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mallinckrodt Pharmaceuticals
7.1.1 Mallinckrodt Pharmaceuticals Company Information
7.1.2 Mallinckrodt Pharmaceuticals Introduction and Business Overview
7.1.3 Mallinckrodt Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mallinckrodt Pharmaceuticals Powerful Analgesics Product Offerings
7.1.5 Mallinckrodt Pharmaceuticals Recent Development
7.2 Alcaliber
7.2.1 Alcaliber Company Information
7.2.2 Alcaliber Introduction and Business Overview
7.2.3 Alcaliber Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alcaliber Powerful Analgesics Product Offerings
7.2.5 Alcaliber Recent Development
7.3 Purdue Pharma
7.3.1 Purdue Pharma Company Information
7.3.2 Purdue Pharma Introduction and Business Overview
7.3.3 Purdue Pharma Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Purdue Pharma Powerful Analgesics Product Offerings
7.3.5 Purdue Pharma Recent Development
7.4 Sanofi Winthrop Industrie
7.4.1 Sanofi Winthrop Industrie Company Information
7.4.2 Sanofi Winthrop Industrie Introduction and Business Overview
7.4.3 Sanofi Winthrop Industrie Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Sanofi Winthrop Industrie Powerful Analgesics Product Offerings
7.4.5 Sanofi Winthrop Industrie Recent Development
7.5 Macfarlan Smith
7.5.1 Macfarlan Smith Company Information
7.5.2 Macfarlan Smith Introduction and Business Overview
7.5.3 Macfarlan Smith Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Macfarlan Smith Powerful Analgesics Product Offerings
7.5.5 Macfarlan Smith Recent Development
7.6 Akorn
7.6.1 Akorn Company Information
7.6.2 Akorn Introduction and Business Overview
7.6.3 Akorn Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Akorn Powerful Analgesics Product Offerings
7.6.5 Akorn Recent Development
7.7 Barr Pharmaceuticals
7.7.1 Barr Pharmaceuticals Company Information
7.7.2 Barr Pharmaceuticals Introduction and Business Overview
7.7.3 Barr Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Barr Pharmaceuticals Powerful Analgesics Product Offerings
7.7.5 Barr Pharmaceuticals Recent Development
7.8 Pfizer
7.8.1 Pfizer Company Information
7.8.2 Pfizer Introduction and Business Overview
7.8.3 Pfizer Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Pfizer Powerful Analgesics Product Offerings
7.8.5 Pfizer Recent Development
7.9 Watson Laboratories
7.9.1 Watson Laboratories Company Information
7.9.2 Watson Laboratories Introduction and Business Overview
7.9.3 Watson Laboratories Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Watson Laboratories Powerful Analgesics Product Offerings
7.9.5 Watson Laboratories Recent Development
7.10 Teva
7.10.1 Teva Company Information
7.10.2 Teva Introduction and Business Overview
7.10.3 Teva Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Teva Powerful Analgesics Product Offerings
7.10.5 Teva Recent Development
7.11 KV Pharmaceutical
7.11.1 KV Pharmaceutical Company Information
7.11.2 KV Pharmaceutical Introduction and Business Overview
7.11.3 KV Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.11.4 KV Pharmaceutical Powerful Analgesics Product Offerings
7.11.5 KV Pharmaceutical Recent Development
7.12 Lannett
7.12.1 Lannett Company Information
7.12.2 Lannett Introduction and Business Overview
7.12.3 Lannett Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Lannett Powerful Analgesics Product Offerings
7.12.5 Lannett Recent Development
7.13 Apotex
7.13.1 Apotex Company Information
7.13.2 Apotex Introduction and Business Overview
7.13.3 Apotex Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Apotex Powerful Analgesics Product Offerings
7.13.5 Apotex Recent Development
7.14 Fresenius
7.14.1 Fresenius Company Information
7.14.2 Fresenius Introduction and Business Overview
7.14.3 Fresenius Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Fresenius Powerful Analgesics Product Offerings
7.14.5 Fresenius Recent Development
7.15 Johnson and Johnson
7.15.1 Johnson and Johnson Company Information
7.15.2 Johnson and Johnson Introduction and Business Overview
7.15.3 Johnson and Johnson Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Johnson and Johnson Powerful Analgesics Product Offerings
7.15.5 Johnson and Johnson Recent Development
7.16 Mundipharma
7.16.1 Mundipharma Company Information
7.16.2 Mundipharma Introduction and Business Overview
7.16.3 Mundipharma Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Mundipharma Powerful Analgesics Product Offerings
7.16.5 Mundipharma Recent Development
7.17 Novartis
7.17.1 Novartis Company Information
7.17.2 Novartis Introduction and Business Overview
7.17.3 Novartis Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Novartis Powerful Analgesics Product Offerings
7.17.5 Novartis Recent Development
7.18 Stada Arzneimittel
7.18.1 Stada Arzneimittel Company Information
7.18.2 Stada Arzneimittel Introduction and Business Overview
7.18.3 Stada Arzneimittel Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Stada Arzneimittel Powerful Analgesics Product Offerings
7.18.5 Stada Arzneimittel Recent Development
7.19 Mylan
7.19.1 Mylan Company Information
7.19.2 Mylan Introduction and Business Overview
7.19.3 Mylan Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Mylan Powerful Analgesics Product Offerings
7.19.5 Mylan Recent Development
7.20 Endo Pharmaceuticals
7.20.1 Endo Pharmaceuticals Company Information
7.20.2 Endo Pharmaceuticals Introduction and Business Overview
7.20.3 Endo Pharmaceuticals Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Endo Pharmaceuticals Powerful Analgesics Product Offerings
7.20.5 Endo Pharmaceuticals Recent Development
7.21 Sun Pharmaceutical Industries
7.21.1 Sun Pharmaceutical Industries Company Information
7.21.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.21.3 Sun Pharmaceutical Industries Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Sun Pharmaceutical Industries Powerful Analgesics Product Offerings
7.21.5 Sun Pharmaceutical Industries Recent Development
7.22 Northeast Pharmaceutical Group
7.22.1 Northeast Pharmaceutical Group Company Information
7.22.2 Northeast Pharmaceutical Group Introduction and Business Overview
7.22.3 Northeast Pharmaceutical Group Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Northeast Pharmaceutical Group Powerful Analgesics Product Offerings
7.22.5 Northeast Pharmaceutical Group Recent Development
7.23 Shandong Keyuan Pharmaceutical
7.23.1 Shandong Keyuan Pharmaceutical Company Information
7.23.2 Shandong Keyuan Pharmaceutical Introduction and Business Overview
7.23.3 Shandong Keyuan Pharmaceutical Powerful Analgesics Sales, Revenue and Gross Margin (2019-2024)
7.23.4 Shandong Keyuan Pharmaceutical Powerful Analgesics Product Offerings
7.23.5 Shandong Keyuan Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Powerful Analgesics Industrial Chain
8.2 Powerful Analgesics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Powerful Analgesics Sales Model
8.5.2 Sales Channel
8.5.3 Powerful Analgesics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Akorn
Barr Pharmaceuticals
Pfizer
Watson Laboratories
Teva
KV Pharmaceutical
Lannett
Apotex
Fresenius
Johnson and Johnson
Mundipharma
Novartis
Stada Arzneimittel
Mylan
Endo Pharmaceuticals
Sun Pharmaceutical Industries
Northeast Pharmaceutical Group
Shandong Keyuan Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.